Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals Revenue

In the year 2023, Syros Pharmaceuticals had annual revenue of $9.94M, a decrease of -33.23%. Revenue in the quarter ending December 31, 2023 was $386.00K, a -151.19% decrease year-over-year.

• Revenue (ttm): $9.94M
• Revenue Growth: -33.23%
• P/S Ratio: 14.47
• Revenue / Employee: $146,118
• Employees: 68
• Market Cap: 142.73M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.94M	-4.94M	-33.23%
Dec 31, 2022	14.88M	-8.61M	-36.65%
Dec 31, 2021	23.49M	8.40M	55.62%
Dec 31, 2020	15.09M	13.11M	661.50%
Dec 31, 2019	1.98M	-68.00K	-3.32%
Dec 31, 2018	2.05M	949.00K	86.19%
Dec 31, 2017	1.10M	784.00K	247.32%
Dec 31, 2016	317.00K	-	-
Dec 31, 2015	317.00K	-	-
Dec 31, 2014	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.